HONG KONG (Indonesia Today) – Sinopharm Group Co Ltd, one of the leading pharmaceutical companies in China, booked net profit of RMB240 million in the first half ended June 30, 2012, jumps 45.61% from the corresponding period of 2011.
Sinopharm reported sales revenue of RMB8.8 billion in the first half, an increase of 22.1% from the same period last year, while operating profit surged 57% to RMB317.96 million.
As of June 30, 2012, Sinopharm had total assets and equity of RMB8.66 billion and RMB1.55 billion respectively.